Traders Purchase Large Volume of Call Options on ASP Isotopes (NASDAQ:ASPI)

ASP Isotopes Inc. (NASDAQ:ASPI) saw some unusual options trading on Friday. Traders bought 24,375 call options on the stock. This is an increase of 32% compared to the typical volume of 18,511 call options.

ASP Isotopes Trading Up 18.1%

NASDAQ:ASPI traded up $1.16 on Friday, hitting $7.60. 12,904,457 shares of the stock were exchanged, compared to its average volume of 5,753,380. The company’s 50-day moving average price is $6.67 and its 200 day moving average price is $8.39. ASP Isotopes has a 52 week low of $3.65 and a 52 week high of $14.49. The stock has a market capitalization of $842.83 million, a price-to-earnings ratio of -5.84 and a beta of 3.47. The company has a debt-to-equity ratio of 1.04, a quick ratio of 6.10 and a current ratio of 6.14.

ASP Isotopes (NASDAQ:ASPI) last posted its earnings results on Wednesday, November 19th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.05). ASP Isotopes had a negative net margin of 1,259.12% and a negative return on equity of 190.44%. The business had revenue of $4.89 million during the quarter, compared to analyst estimates of $2.25 million. On average, equities research analysts forecast that ASP Isotopes will post -0.24 earnings per share for the current year.

Insider Activity

In other ASP Isotopes news, Chairman Paul Elliot Mann sold 162,153 shares of the company’s stock in a transaction dated Monday, December 1st. The shares were sold at an average price of $5.75, for a total value of $932,379.75. Following the completion of the transaction, the chairman owned 7,759,538 shares in the company, valued at approximately $44,617,343.50. This represents a 2.05% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Heather Kiessling sold 80,000 shares of the business’s stock in a transaction on Thursday, December 18th. The stock was sold at an average price of $5.80, for a total value of $464,000.00. Following the transaction, the chief financial officer owned 732,500 shares of the company’s stock, valued at $4,248,500. This trade represents a 9.85% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 528,091 shares of company stock valued at $3,539,245. 14.40% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On ASP Isotopes

Several institutional investors and hedge funds have recently made changes to their positions in the company. Exchange Traded Concepts LLC acquired a new stake in ASP Isotopes during the 2nd quarter worth about $9,593,000. AlphaQuest LLC purchased a new stake in shares of ASP Isotopes in the second quarter worth approximately $256,000. Rovida Advisors Inc. purchased a new stake in shares of ASP Isotopes in the second quarter valued at about $16,148,000. Universal Beteiligungs und Servicegesellschaft mbH bought a new position in shares of ASP Isotopes during the 2nd quarter worth approximately $331,000. Finally, Harbour Capital Advisors LLC bought a new position in ASP Isotopes in the 2nd quarter valued at $232,000. Institutional investors and hedge funds own 16.80% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on ASPI. Loop Capital set a $15.00 price objective on shares of ASP Isotopes in a research note on Monday, October 27th. Canaccord Genuity Group reissued a “buy” rating and issued a $11.00 price objective on shares of ASP Isotopes in a research note on Monday, November 24th. Cantor Fitzgerald started coverage on ASP Isotopes in a research note on Thursday, December 4th. They issued an “overweight” rating and a $13.00 price objective on the stock. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of ASP Isotopes in a report on Monday, December 29th. Two research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $13.00.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.